Quoin Pharmaceuticals, Ltd. (QNRX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -4.87M | -5.08M | -2.23M | -3.69M | -2.59M | -2.24M | -2.18M | -2.01M | -1.43M | -3.22M | -1.32M | -1.57M | -1.75M | -2.29M | -2.29M | -2.15M | -2.09M | -3.18M | -136.96K | -1.22M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -87.69% | -127.2% | -2.12% | -83.66% | -80.86% | 30.62% | -64.91% | -27.62% | 17.87% | -40.81% | 42.38% | 26.9% | 16.58% | 27.98% | -1574.51% | -76.34% | -406.03% | -485.29% | - | - |
| Net Income | -5M | -15.79B | -3.95M | -3.7M | -3.81M | -2.31M | -2.35M | -1.97M | -2.33M | -2.05M | -1.93M | -2.11M | -2.6M | -2M | -3.03M | -2.67M | -1.68M | -11.82M | -1.41M | -4.34M |
| Depreciation & Amortization | 25K | 99.92M | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25.67K | 26.01K | 26.01K | 26.01K | 25.94K | 26.01K | 26.01K | 26.01K | 26.01K | 0 | 26.01K |
| Stock-Based Compensation | 444.52K | 1.15B | 182K | 321K | 360.36K | 325.89K | 313K | 682K | 306.31K | 300.2K | 268.5K | 264K | 261.47K | 0 | 267K | 229K | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -111.15K | 14.54B | 1.43M | -591.56K | -67.06K | 319.06K | -544.17K | -664.3K | 545.46K | -1.1M | -138.71K | 79.53K | 451.37K | 538.84K | -289.44K | 279.13K | -642.77K | 8.26M | 131.33K | 3.16M |
| Working Capital Changes | -229.56K | -923.48K | 86.28K | 255.17K | 899.71K | -595.2K | 376.76K | -75.79K | 16.13K | -398.6K | 449.35K | 164.68K | 117.68K | -858.45K | 732.53K | -17.34K | 206.01K | 350.73K | 1.14M | -66.63K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -200.9K | -259.36K | 0 | 0 | 674.68K | 0 | 0 | 0 | 0 | 0 | 286.21K | 0 | 0 | -70.04K | 0 | 0 | 0 | 885.68K | 372.9K | -269.14K |
| Cash from Investing | 4.12M | -11.35M | 2.54M | 1.68M | 2.77M | -3.18M | 2.6M | 3.15M | -4.47M | 2.64M | 821 | 3.04M | -3.49M | -68.45K | -9.9M | -200K | -50K | -250K | -374.62K | -125K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.69K | 0 | 0 | 0 | -250K | -374.62K | -125K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 5.1M | -6.36B | 2.54M | 1.68M | -172.96K | -3.18M | 2.6M | 3.15M | -4.47M | 2.64M | 0 | 3.04M | -3.49M | 0 | -9.9M | -200K | -50K | 0 | 0 | 0 |
| Cash from Financing | 55.98K | 18.44M | -150K | -150K | 22.96K | 5.92M | -149.89K | -136.28K | 5.33M | -182.58K | -275K | -75K | 5.75M | -37.18K | 14.75M | -150K | -150K | 10.26M | 3.27M | 1.99M |
| Debt Issued (Net) | 0 | 0 | -150K | -150K | -150K | -150K | -150K | -150K | -150K | -150K | -275K | -75K | -100K | 0 | -150K | -150K | -150K | 0 | 3.47M | 2.06M |
| Equity Issued (Net) | 205.42K | 18.59M | 0 | 0 | 172.06K | 0 | 0 | 0 | 0 | 0 | -13.52K | 0 | 0 | 73.39K | 0 | 0 | 0 | 0 | -197.84K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -149.44K | -151.53K | 0 | 0 | 899 | 6.07M | 108 | 13.72K | 5.48M | -32.58K | 13.52K | 0 | 5.85M | -110.57K | 14.9M | 0 | 0 | 10.26M | -80 | -76.97K |
| Net Change in Cash | -693.57K | 1.99M | 162.41K | -2.15M | 198.78K | 506.59K | 271.62K | 1.01M | -567.67K | -762.23K | -1.6M | 1.39M | 511.23K | -2.39M | 2.56M | -2.5M | -2.29M | 6.83M | -2.02M | 642.8K |
| Free Cash Flow | -4.87M | -5.08M | -2.23M | -3.69M | -2.59M | -2.24M | -2.18M | -2.01M | -1.43M | -3.22M | -1.32M | -1.57M | -1.75M | -2.29M | -2.29M | -2.15M | -2.09M | -3.43M | -136.96K | -1.35M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -87.69% | -127.2% | -2.12% | -83.66% | -80.86% | 30.62% | -64.91% | -27.62% | 17.87% | -40.81% | 42.38% | 26.9% | 16.58% | 33.23% | -1574.55% | -59.95% | -276.39% | -531.32% | - | - |
| FCF per Share | -2.48 | -3.39 | -3.78 | -6.27 | -4.42 | -11.99 | -0.44 | -0.40 | -0.68 | -3.27 | -1.34 | -1.59 | -1.77 | -5.67 | -8.36 | -7.84 | -37.44 | -75.85 | -6.84 | -67.16 |
| FCF Conversion (FCF/Net Income) | 0.98x | 1.17x | 0.56x | 1.00x | 0.68x | 0.97x | 0.93x | 1.02x | 0.62x | 1.57x | 0.69x | 0.75x | 0.67x | 1.14x | 0.76x | 0.81x | 1.24x | 0.27x | 0.10x | 0.28x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |